3-[(4-hydroxy-3,5-dimethylphenyl)methylamino]-5-[(5-morpholin-4-yl-2-pyridinyl)methyl]-1H-pyrazole-4-carboxamide
C23H28N6O3 — CID 158834110
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[(4-hydroxy-3,5-dimethylphenyl)methylamino]-5-[(5-morpholin-4-yl-2-pyridinyl)methyl]-1H-pyrazole-4-carboxamide
3-[(4-hydroxy-3,5-dimethylphenyl)methylamino]-5-[(5-morpholin-4-yl-2-pyridinyl)methyl]-1H-pyrazole-4-carboxamide (PubChem CID 158834110) has the molecular formula C23H28N6O3 and a molecular weight of 436.52 g/mol. Its IUPAC name is 3-[(4-hydroxy-3,5-dimethylphenyl)methylamino]-5-[(5-morpholin-4-yl-2-pyridinyl)methyl]-1H-pyrazole-4-carboxamide.
Molecular Properties
| Compound Name | 3-[(4-hydroxy-3,5-dimethylphenyl)methylamino]-5-[(5-morpholin-4-yl-2-pyridinyl)methyl]-1H-pyrazole-4-carboxamide |
|---|---|
| PubChem CID | 158834110 |
| Molecular Formula | C23H28N6O3 |
| Molecular Weight | 436.52 g/mol |
| Exact Mass | 436.22 |
| IUPAC Name | 3-[(4-hydroxy-3,5-dimethylphenyl)methylamino]-5-[(5-morpholin-4-yl-2-pyridinyl)methyl]-1H-pyrazole-4-carboxamide |
| SMILES | Cc1cc(CNc2n[nH]c(Cc3ccc(N4CCOCC4)cn3)c2C(N)=O)cc(C)c1O |
| InChI | InChI=1S/C23H28N6O3/c1-14-9-16(10-15(2)21(14)30)12-26-23-20(22(24)31)19(27-28-23)11-17-3-4-18(13-25-17)29-5-7-32-8-6-29/h3-4,9-10,13,30H,5-8,11-12H2,1-2H3,(H2,24,31)(H2,26,27,28) |
| InChIKey | IXKKFQUACYZQJM-UHFFFAOYSA-N |
| XLogP | 2.27 |
| TPSA | 129.39 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.52 |
| LogP ≤ 5 | 2.27 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158834110 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.